albendazole has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
Lymphoma, Large-Cell, Anaplastic: A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called hallmark cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehman, JU | 1 |
| Rao, TV | 1 |
| AlKindi, S | 1 |
| Dennison, D | 1 |
| Pathare, AV | 1 |
1 other study available for albendazole and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
Topics: Adult; Albendazole; Anthelmintics; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; | 2007 |